| abstract |
The present invention provides methods for treating individuals having a hepatitis C virus (HCV) infection, which individuals havefailed to respond to therapy with an IFN-α other than consensus interferon (CIFN), or who, following cessation of therapy withan IFN-α other than CIFN, have suffered relapse. The methods generally involve a treatment regimen comprising administering a first dosing regimen of CIFN, followed by a second dosing regimenof CIFN. Ribavirin is administered with at least the second dosing regimen. |